ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.

BACKGROUND Monogenic autoinflammatory diseases are caused by pathogenic variants in genes that regulate innate immune responses, and are characterized by sterile systemic inflammatory episodes. Since symptoms can overlap within this rapidly expanding disease category, accurate genetic diagnosis is of the utmost importance to initiate early inflammation-targeted treatment and prevent clinically significant or life-threatening complications. Initial recommendations for the genetic diagnosis of autoinflammatory diseases were limited to a gene-by-gene diagnosis strategy based on the Sanger method, and restricted to the 4 prototypic recurrent fevers (MEFV, MVK, TNFRSF1A, and NLRP3 genes). The development of best practices guidelines integrating critical recent discoveries has become essential. METHODS The preparatory steps included 2 online surveys and pathogenicity annotation of newly recommended genes. The current guidelines were drafted by European Molecular Genetics Quality Network members, then discussed by a panel of experts of the International Society for Systemic Autoinflammatory Diseases during a consensus meeting. RESULTS In these guidelines, we combine the diagnostic strength of next-generation sequencing and recommendations to 4 more recently identified genes (ADA2, NOD2, PSTPIP1, and TNFAIP3), nonclassical pathogenic genetic alterations, and atypical phenotypes. We present a referral-based decision tree for test scope and method (Sanger versus next-generation sequencing) and recommend on complementary explorations for mosaicism, copy-number variants, and gene dose. A genotype table based on the 5-category variant pathogenicity classification provides the clinical significance of prototypic genotypes per gene and disease. CONCLUSIONS These guidelines will orient and assist geneticists and health practitioners in providing up-to-date and appropriate diagnosis to their patients.

[1]  K. Choate,et al.  Second-Hit Somatic Mutations in Mevalonate Pathway Genes Underlie Porokeratosis. , 2019, The Journal of investigative dermatology.

[2]  S. Patton,et al.  Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network Survey , 2019, European Journal of Human Genetics.

[3]  S. Georgin-lavialle,et al.  Autoinflammatory diseases: State of the art. , 2019, Presse medicale.

[4]  Todd W. Lyons,et al.  Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. , 2018, The Journal of allergy and clinical immunology.

[5]  F. Xia,et al.  PSTPIP1‐associated myeloid‐related proteinemia inflammatory syndrome: A rare cause of childhood neutropenia associated with systemic inflammation and hyperzincemia , 2018, Pediatric blood & cancer.

[6]  D. Kastner,et al.  Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study , 2018, Annals of the rheumatic diseases.

[7]  I. Touitou,et al.  Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review , 2018, Critical reviews in clinical laboratory sciences.

[8]  P. Soler-Palacín,et al.  TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6. , 2018, Clinical immunology.

[9]  K. Heimdal,et al.  A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience , 2018, European Journal of Human Genetics.

[10]  M. Swertz,et al.  New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID) , 2018, Journal of Medical Genetics.

[11]  M. Hershfield,et al.  Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders , 2017, Current Rheumatology Reports.

[12]  D. Kastner,et al.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation , 2017, Nature Immunology.

[13]  G. Damonte,et al.  ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study , 2017, Annals of the rheumatic diseases.

[14]  P. Hawkins,et al.  Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue—a case series and genetic exploration , 2017, Rheumatology.

[15]  J. Cañueto,et al.  PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome , 2016, The British journal of dermatology.

[16]  Y. Crow,et al.  ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters , 2016, RMD Open.

[17]  Keiko Kobayashi,et al.  Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease , 2016, RMD Open.

[18]  Laura F. Dagley,et al.  Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation , 2016, Science Translational Medicine.

[19]  J. Mullikin,et al.  Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early onset autoinflammatory syndrome , 2015, Nature Genetics.

[20]  J. Yagüe,et al.  Somatic NOD2 mosaicism in Blau syndrome. , 2015, The Journal of allergy and clinical immunology.

[21]  L. Punzi,et al.  Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease , 2015, RMD Open.

[22]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[23]  P. Jansen,et al.  Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome. , 2015, The Journal of allergy and clinical immunology.

[24]  J. Bertin,et al.  Blau Syndrome, the prototypic auto-inflammatory granulomatous disease , 2014, Pediatric Rheumatology.

[25]  J. Mullikin,et al.  Early-onset stroke and vasculopathy associated with mutations in ADA2. , 2014, The New England journal of medicine.

[26]  T. Walsh,et al.  Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. , 2014, The New England journal of medicine.

[27]  I. Touitou.  Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature , 2013, Journal of Medical Genetics.

[28]  C. Wijmenga,et al.  MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease , 2013, Annals of the rheumatic diseases.

[29]  I. Touitou,et al.  Guidelines for the genetic diagnosis of hereditary recurrent fevers , 2012, Annals of the rheumatic diseases.

[30]  C. Wouters,et al.  An International registry on Autoinflammatory diseases: the Eurofever experience , 2012, Annals of the rheumatic diseases.

[31]  D. Booth,et al.  Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. , 2007, Arthritis and rheumatism.

[32]  T. Nakahata,et al.  Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. , 2005, Arthritis and rheumatism.

[33]  A. Utani,et al.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. , 2004, Blood.

[34]  J. Hugot,et al.  Infevers: An evolving mutation database for auto‐inflammatory syndromes , 2004, Human mutation.

[35]  Judy H. Cho,et al.  The genetics of inflammatory bowel disease. , 2003, Gastroenterology.

[36]  M. Lovett,et al.  Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. , 2002, Human molecular genetics.

[37]  G. Thomas,et al.  CARD15 mutations in Blau syndrome , 2001, Nature Genetics.

[38]  Jacques Demaille,et al.  A candidate gene for familial Mediterranean fever , 1997, Nature Genetics.

[39]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[40]  Dr R B McCONNEDL.  The Genetics of Inflammatory Bowel Disease , 1979 .

[41]  J. Yagüe,et al.  A severe autosomal‐dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: An unusual familial Mediterranean fever phenotype or another MEFV‐associated periodic inflammatory disorder? , 2004, American journal of medical genetics. Part A.